Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Metabolic management of brain cancer.

Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P.

Biochim Biophys Acta. 2011 Jun;1807(6):577-94. doi: 10.1016/j.bbabio.2010.08.009. Epub 2010 Sep 8. Review.

2.

Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet.

Seyfried BT, Kiebish M, Marsh J, Mukherjee P.

J Cancer Res Ther. 2009 Sep;5 Suppl 1:S7-15. doi: 10.4103/0973-1482.55134. Review.

3.

Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets.

Seyfried TN, Kiebish M, Mukherjee P, Marsh J.

Epilepsia. 2008 Nov;49 Suppl 8:114-6. doi: 10.1111/j.1528-1167.2008.01853.x. Review.

4.

Metabolic therapy: a new paradigm for managing malignant brain cancer.

Seyfried TN, Flores R, Poff AM, D'Agostino DP, Mukherjee P.

Cancer Lett. 2015 Jan 28;356(2 Pt A):289-300. doi: 10.1016/j.canlet.2014.07.015. Epub 2014 Jul 25. Review.

PMID:
25069036
5.

Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?

Seyfried TN, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P.

Epilepsy Res. 2012 Jul;100(3):310-26. doi: 10.1016/j.eplepsyres.2011.06.017. Epub 2011 Aug 31. Review.

PMID:
21885251
6.
7.

Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme.

Maroon J, Bost J, Amos A, Zuccoli G.

J Child Neurol. 2013 Aug;28(8):1002-8. doi: 10.1177/0883073813488670. Epub 2013 May 13. Review.

PMID:
23670248
8.

Energy metabolism in developing brain cells.

Edmond J.

Can J Physiol Pharmacol. 1992;70 Suppl:S118-29. Review.

PMID:
1295662
9.

The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

Maalouf M, Rho JM, Mattson MP.

Brain Res Rev. 2009 Mar;59(2):293-315. doi: 10.1016/j.brainresrev.2008.09.002. Epub 2008 Sep 25. Review.

10.

The ketogenic diet for the treatment of malignant glioma.

Woolf EC, Scheck AC.

J Lipid Res. 2015 Jan;56(1):5-10. doi: 10.1194/jlr.R046797. Epub 2014 Feb 6. Review.

11.

[Cellular energetic metabolism of cerebral tissue: metabolic characteristics of glial tumours].

La Schiazza R, Lamari F, Foglietti MJ, Hainque B, Bernard M, Beaudeux JL.

Ann Biol Clin (Paris). 2008 Mar-Apr;66(2):131-41. doi: 10.1684/abc.2008.0205. Review. French.

PMID:
18390423
12.

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

Sas K, Robotka H, Toldi J, Vécsei L.

J Neurol Sci. 2007 Jun 15;257(1-2):221-39. Epub 2007 Apr 25. Review.

PMID:
17462670
13.

A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.

Heininger K.

Rev Neurosci. 2000;11 Spec No:213-328. Review.

PMID:
11065271
14.

Mitochondrial response to controlled nutrition in health and disease.

Schiff M, Bénit P, Coulibaly A, Loublier S, El-Khoury R, Rustin P.

Nutr Rev. 2011 Feb;69(2):65-75. doi: 10.1111/j.1753-4887.2010.00363.x. Epub 2011 Jan 14. Review.

PMID:
21294740
15.

Glioblastoma and stem cells.

Altaner C.

Neoplasma. 2008;55(5):369-74. Review.

PMID:
18665745
16.

Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

Lefranc F, Rynkowski M, DeWitte O, Kiss R.

Adv Tech Stand Neurosurg. 2009;34:3-35. Review.

PMID:
19368079
17.

Current concepts and management of glioblastoma.

Preusser M, de Ribaupierre S, Wöhrer A, Erridge SC, Hegi M, Weller M, Stupp R.

Ann Neurol. 2011 Jul;70(1):9-21. doi: 10.1002/ana.22425. Review.

PMID:
21786296
18.
20.

KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders.

Smith SL, Heal DJ, Martin KF.

CNS Drug Rev. 2005 Summer;11(2):113-40. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk